InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
无可用的信号评分。
Explore the full record of transactions filed by Kocak Ron. Director active across 1 company, notably RenovoRx, Inc.. Cumulatively, 1 disclosures have been logged. Split: 1 buy · 0 sell. Total volume traded: €69. History available since 8 April 2025. The latest transaction was disclosed on 8 April 2025 (Acquisition). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.